Data and Safety Monitoring (DSMB)
An independent DSMB will assess any reports of adverse
events and will recommend to the researchers if the trial
should continue, be modified or stopped. The DSMB will
consist of three representatives from Toronto, Edmonton
and Chicago. Teleconferences will be scheduled annually